Repligen Corp Stock Ownership - Who owns Repligen?

Insider buying vs selling

Have Repligen Corp insiders been buying or selling?
Anthony HuntChief Executive Officer2024-06-142,000$124.08
Martin D. MadausDirector2024-06-14915$124.54
Martin D. MadausDirector2024-06-14700$125.46
Nicolas BarthelemyDirector2024-06-141,200$125.45
Karen A. DawesDirector2024-06-142,953$67.71
Anthony HuntChief Executive Officer2024-05-214,274$166.36
Anthony HuntChief Executive Officer2024-05-214,008$167.05
Anthony HuntChief Executive Officer2024-05-213,933$168.33
Anthony HuntChief Executive Officer2024-05-212,963$169.27
Anthony HuntChief Executive Officer2024-05-213,925$170.04

1 of 5

RGEN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RGEN insiders and whales buy or sell their stock.

RGEN Shareholders

What type of owners hold Repligen Corp stock?
Bvf Partners L P19.79%11,060,200$1.39BInsider
Blackrock Inc13.91%7,773,131$978.95MInstitution
Roy T. Eddleman13.76%7,685,810$967.95MInsider
Vanguard Group Inc9.13%5,100,013$642.30MInstitution
Price T Rowe Associates Inc6.39%3,568,316$449.39MInstitution
Fmr LLC4.04%2,257,789$284.35MInstitution
State Street Corp3.15%1,758,212$221.43MInstitution
Macquarie Group Ltd2.62%1,464,602$184.45MInstitution
Sands Capital Management LLC2.56%1,432,737$180.44MInstitution
Invesco Ltd2.22%1,242,743$156.51MInstitution

1 of 3

RGEN vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RGEN72.70%27.30%Net SellingNet Selling
XRAY97.74%2.26%Net SellingNet Selling
BLCO10.68%88.95%Net SellingNet Selling
MMSI94.95%5.05%Net BuyingNet Buying

Repligen Stock Ownership FAQ

Who owns Repligen?

Repligen (NASDAQ: RGEN) is owned by 100.30% institutional shareholders, 37.66% Repligen insiders, and 0.00% retail investors. Bvf Partners L P is the largest individual Repligen shareholder, owning 11.06M shares representing 19.79% of the company. Bvf Partners L P's Repligen shares are currently valued at $1.39B.

If you're new to stock investing, here's how to buy Repligen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.